Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease

Journal of Hepatology

Volumn 41, Issue 1, 2004, Pages 31-37

  Longhi, Maria Serena ^a   Ma, Yun ^a   Bogdanos, Dimitrios P ^a   Cheeseman, Paul ^a   Mieli Vergani, Giorgina ^a   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

ANA, anti nuclear antibodies; Autoimmunity; IL 2R, interleukin 2 receptor; Liver disease; LKM1, liver kidney microsomal antibody type 1; Regulatory T cells; SLA, soluble liver antigen; SMA, anti smooth muscle antibodies; T regs, regulatory T cells

Indexed keywords

AUTOANTIBODY; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; LIVER ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIVER DISEASE; LIVER MICROSOME; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; SAMPLE SIZE; T LYMPHOCYTE ACTIVATION;

AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; HEPATITIS, AUTOIMMUNE; HUMANS; INTERFERON TYPE II; RECEPTORS, INTERLEUKIN-2;

EID: 3442885909     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.03.008     Document Type: Article

References (46)

1. Shevach E.M. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2:2002;389-400
2. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 10:1998;1969-1980
3. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 188:1998;287-296
4. Annacker O., Pimenta-Araujo R., Burlen-Defranoux O., Barbosa T.C., Cumano A., Bandeira A. CD25+CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol. 166:2001;3008-3018
5. Thornton A.M., Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific. J Immunol. 164:2000;183-190
6. pos regulatory cells. Autoimmun Rev. 1:2002;190-197
7. Walker M.R., Kasprowicz D.J., Gersuk V.H., Bènard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest. 112:2003;1437-1443
8. Alyanakian M.A., You S., Damotte D., Gouarin C., Esling A., Garcia C., et al. Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases. Proc Natl Acad Sci USA. 100:2003;15806-15811
9. Fu S., Yopp A.C., Mao X., Chen D., Zhang N., Chen D., et al. CD4+CD25+CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant. 4:2004;65-78
10. Sakaguchi S., Fukuma K., Kuribayashi K., Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. J Exp Med. 161:1985;72-87
11. Dieckemann D., Plottner H., Berchtold S., Berger T., Schuler G. Ex vivo isolation of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med. 193:2001;1303-1310
12. Ng W.F., Duggan P.J., Ponchel F., Matarese G., Lombardi G., Edwards A.D., et al. CD4 (+) CD25 (+) T cells: a naturally occurring population of regulatory T cells. Blood. 98:2001;2736-2744
13. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med. 193:2001;1285-1294
14. Baecher-Allan C., Brown J.A., Freeman G.J., Hafler D.A. CD4+CD25+ high regulatory cells in human peripheral blood. J Immunol. 167:2001;1245-1253
15. Gregorio G.V., Portmann B., Reid F., Donaldson P.T., Doherty D.G., McCartney M., et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology. 25:1997;541-547
16. Mieli-Vergani G., Vergani D. Progress in pediatric autoimmune hepatitis. Semin Liver Dis. 14:1994;282-288
17. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review criteria for the diagnosis of autoimmune hepatitis. J Hepatol. 31:1999;929-938
18. Muratoria L., Parolac M., Ripaltib A., Robinoc G., Muratoria P., Bellomod G., et al. Liver/kidney microsomal antibody type 1 targets CYP 2D6 on hepatocyte plasma membrane. Gut. 46:2000;553-561
19. Homberg J.C., Abuaf N., Bernard O., Islam S., Alvarez F., Khalil S.H., et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: a second type of 'autoimmune' hepatitis. Hepatology. 7:1987;1333-1339
20. Gregorio G.V., Portmann B., Karani J., Harrison P., Donaldson P.T., Vergani D., et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology. 33:2001;544-553
21. Ma Y., Okamoto M., Thomas M.G., Bogdanos D.P., Lopes A.R., Portmann B., et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology. 35:2002;658-664
22. Hengstler J.G., Ringel M., Biefang K., Hammel S., Milbert U., Gerl M., et al. Cultures with cryopreserved hepatocytes: applicability for studies of enzyme induction. Chem Biol Interact. 125:2000;51-73
23. Jiang S., Camara N., Lombardi G., Lechler R.I. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex-vivo. Blood. 102:2003;2180-2186
24. Smith M., Williams R., Walker G., Rizzetto M., Doniach D. Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J. 2:1974;80-84
25. Manns M.P., Gerken G., Kyriatsoulis A., Staritz M., Meyer zum Büschenfelde K.H. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. 1:1987;292-294
26. Wächter B., Kyriatsoulis A., Lohse A.W., Gerken G., Meyer zum Büschenfelde K.H., Manns M. Characterisation of a liver cytokeratin as a major target antigen of anti-SLA antibodies. J Hepatol. 11:1990;232-239
27. Wies I., Brunner S., Henninger J., Herkel J., Kanzier S., Meyer zum Büschenfelde K.H., et al. Identification of target for SLA/LP autoantibodies in autoimmune hepatitis. Lancet. 355:2000;1510-1515
28. Bystry R.S., Aluvihare V., Welch K.A., Kallikourdis M., Betz A.G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol. 2:2001;1126-1132
29. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 184:1996;387-396
30. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). J Immunol. 155:1995;1151-1164
31. Crispin J.C., Martinez A., Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 21:2003;273-276
32. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., et al. Multiple immunoregulatory defects in type I diabetes. J Clin Invest. 109:2002;131-140
33. Akbar A.N., Taams L.S., Salmon M., Vukmanovic-Stejic M. The peripheral generation of CD4+CD25+ regulatory T cells. Immunology. 109:2003;319-325
34. Nouri-Aria K.T., Lobo-Yeo A., Vergani D., Mieli-Vergani G., Eddleston A.L.W.F., Mowat A.P. T suppressor cell function and number in children with liver disease. Clin Exp Immunol. 61:1985;283-289
35. Nouri-Aria K.T., Hegarty J.E., Alexander G.J.M., Eddleston A.L.W.F., Williams R. Effect of corticosteroids on suppressor cell activity in autoimmune and viral chronic active hepatitis. N Engl J Med. 307:1982;1301-1304
36. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., Adorini L. Regulatory T cells induced by 1α, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 167:2001;1945-1953
37. Mariotti A., Caturegli P., Barbesino G., Marino M., Del Prete G.F., Chiovato L., et al. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases. Clin Endocrinol. 37:1992;415-422
38. Wortsman J., McConnachie P., Baker J.R. Jr, Mallette L.E. T-lymphocyte activation in adult-onset idiopathic hypoparathyroidism. Am J Med. 92:1992;352-356
39. Lobo-Yeo A., Mieli-Vergani G., Mowat A.P., Vergani D. Soluble interleukin 2 receptors in autoimmune chronic active hepatitis. Gut. 31:1990;690-693
40. Kontiainen S., Toomath R., Lowder J., Feldmann M. Selective activation of T cells in newly diagnosed insulin-dependent diabetic patients: evidence for heterogeneity of T cell receptor usage. Clin Exp Immunol. 83:1991;347-351
41. Kelley V.E., Gaulton G.N., Hattori M., Ikegami H., Eisenbarth G., Strom T.B. Anti-interleukin 2-receptor antibody suppresses murine diabetic insulitis and lupus nephritis. J Immunol. 140:1988;59-61
42. Weissenhorn W., Scheuer W., Kaluza B., Schwirzke M., Reiter C., Flieger D., et al. Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the alpha-chain of the human interleukin-2 receptor. Gene. 121:1992;271-278
43. Winter W.E., Schatz D. Prevention strategies for type 1 diabetes mellitus: current status and future directions. BioDrugs. 17:2003;39-64
44. Kuttler B., Rösing K., Hahn H.J. Anti-CD4/CyA therapy causes prevention of autoimmune but not allogeneic destruction of grafted islets in BB rats. Transplant Proc. 29:1997;2163-2165
45. Cole E., Landsberg D., Russell D., Zaltzman J., Kiberd B., Caravaggio C., et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation. 72:2001;845-850
46. Van Besouw N.M., Balk A.H.M.M., van Vliet M., van der Meide P.H., Maat A.P.W.M., van Gelder T., et al. Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantation. Transplant Proc. 34:2002;2942-2943